Open AccessIntra-arterial chemotherapy as second-line treatment for advanced retinoblastoma
Author(s) -
Hua Jiang,
Gang Shen,
Jiang Yizhou,
Jing Zhang
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_722_17
Subject(s) - medicine , melphalan , ophthalmic artery , surgery , chemotherapy , vincristine , carboplatin , topotecan , etoposide , vitreous hemorrhage , enucleation , refractory (planetary science) , anesthesia , visual acuity , cyclophosphamide , vitrectomy , cisplatin , blood flow , physics , astrobiology
To evaluate the effectiveness and complications of intra-arterial chemotherapy (IAC) for treating advanced refractory retinoblastoma (RB) in a large single-center cohort.